Stati Uniti -
inglese -
NLM (National Library of Medicine)
bloxiverz- neostigmine methylsulfate injection
avadel legacy pharmaceuticals, llc - neostigmine methylsulfate (unii: 98imh7m386) (neostigmine - unii:3982twq96g) - neostigmine methylsulfate 0.5 mg in 1 ml - bloxiverz is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. bloxiverz is contraindicated in patients with: - known hypersensitivity to neostigmine methylsulfate (known hypersensitivity reactions have included urticaria, angioedema, erythema multiforme, generalized rash, facial swelling, peripheral edema, pyrexia, flushing, hypotension, bronchospasm, bradycardia and anaphylaxis). - peritonitis or mechanical obstruction of the intestinal or urinary tract. risk summary there are no adequate or well-controlled studies of bloxiverz in pregnant women. it is not known whether bloxiverz can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. the incidence of malformations in human pregnancies has not been established for neostigmine as the data are limited. all pregnancies, regardless of drug exposure, have a background risk of 2 to 4% for major birth defects, and 15 to 20% for pregnancy loss
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
neostigmine 2.5mg/1ml solution for injection ampoules
hameln pharma ltd - neostigmine metilsulfate - solution for injection - 2.5mg/1ml
Kenya -
inglese -
Pharmacy and Poisons Board
neostigmine inj. 2.5mg/1ml solution for injection
laboratoire renaudin za errobi 64250 itxassou france - neostigmine inj. 2.5mg/1ml - solution for injection - 1 ml of solution contains 2.5 mg of neostigmine… - parasympathomimetics: anticholinesterases
Panama -
inglese -
Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)
neostigmina metilsulfato 0.5 mg/ml, solución inyectable, i.m., i.v., s.c.
laboratorio sanderson s.a. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg
Panama -
inglese -
Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)
neostigmina metilsulfato 0.5mg/ml solucion inyectable i.m., i.v., s.c.
vitalis s.a.c.i. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg
Panama -
inglese -
Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)
neostigmina metil sulfato 0.5 mg/ml solucion inyectable s.c., i.m., i.v.
laboratorios arsal, s.a. de c.v. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg
Canada -
inglese -
Health Canada
pms-neostigmine methylsulfate inj 0.5mg/ml liquid
pharmascience inc - neostigmine methylsulfate - liquid - .5mg - neostigmine methylsulfate .5mg - parasympathomemetic (cholinergic) agents
Canada -
inglese -
Health Canada
pms-neostigmine methylsulfate inj 1mg/ml liquid
pharmascience inc - neostigmine methylsulfate - liquid - 1mg - neostigmine methylsulfate 1mg - parasympathomemetic (cholinergic) agents
Malta -
inglese -
Malta Medicines Authority
neostigmine/cooper solution for injection 2.5mg/ml
cooper s.a. pharmaceuticals 64 aristovoulou str, 11853 k. petralona, athens, greece - neostigmine metilsulfate - solution for injection - neostigmine metilsulfate 2.5 mg/ml - other nervous system drugs
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
neostigmine bromide
lifehealth limited - neostigmine bromide - tablets - 15 milligram